DocGo Inc. (NASDAQ:DCGO) Given Average Rating of “Moderate Buy” by Analysts

DocGo Inc. (NASDAQ:DCGO) has been given an average rating of “Moderate Buy” by the six ratings firms that are covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $3.56.

DCGO has been the subject of several recent research reports. Canaccord Genuity Group reiterated a “hold” rating and set a $1.45 price objective (down from $5.00) on shares of DocGo in a report on Monday, May 12th. Deutsche Bank Aktiengesellschaft lowered DocGo from a “buy” rating to a “hold” rating and cut their price objective for the stock from $5.00 to $2.85 in a report on Friday, February 28th. Stifel Nicolaus cut their price objective on DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a report on Friday, February 28th. BTIG Research lowered DocGo from a “buy” rating to a “neutral” rating in a report on Friday, May 9th. Finally, Needham & Company LLC cut their target price on DocGo from $4.00 to $3.00 and set a “buy” rating on the stock in a report on Friday, May 9th.

DocGo Price Performance

Shares of DCGO stock opened at $1.39 on Wednesday. DocGo has a 12-month low of $1.35 and a 12-month high of $5.68. The firm has a market capitalization of $141.76 million, a price-to-earnings ratio of 4.96, a price-to-earnings-growth ratio of 14.16 and a beta of 1.14. The business has a 50 day simple moving average of $2.30 and a 200 day simple moving average of $3.58.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings data on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.08). DocGo had a net margin of 4.35% and a return on equity of 8.90%. The company had revenue of $96.03 million for the quarter, compared to analyst estimates of $104.25 million. On average, equities analysts anticipate that DocGo will post 0.25 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. JPMorgan Chase & Co. lifted its holdings in DocGo by 151.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company’s stock worth $365,000 after buying an additional 66,097 shares in the last quarter. Matrix Asset Advisors Inc. NY bought a new stake in shares of DocGo during the 4th quarter valued at $424,000. Barclays PLC raised its position in shares of DocGo by 14.5% during the 4th quarter. Barclays PLC now owns 154,456 shares of the company’s stock valued at $655,000 after acquiring an additional 19,533 shares during the last quarter. Vanguard Group Inc. raised its position in shares of DocGo by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 5,014,375 shares of the company’s stock valued at $21,261,000 after acquiring an additional 14,454 shares during the last quarter. Finally, Rhumbline Advisers raised its position in shares of DocGo by 4.5% during the 4th quarter. Rhumbline Advisers now owns 142,762 shares of the company’s stock valued at $605,000 after acquiring an additional 6,204 shares during the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.